Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5304-5312
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5304
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5304
Medication (/kg intraperitoneally) immediately after celecoxib 1 g/kg intraperitoneally | Time after celecoxib | Brain lesions assessment | ||
Microscopic assessment, Score (0-4),Min/Med/Max | Microscopic assessment, Score (0-3), Min/Med/Max | |||
Purkinje cells (red neurons) | Cerebral cortex (red neurons) | Edema | ||
Control, saline 5 mL | 24 h | 2/2/2 | 2/2/2 | 0/0/0 |
48 h | 2/2/3 | 2/2/3 | 0/0/0 | |
BPC 157 10 μg | 24 h | 0/0/0a | 0/1/1a | 0/0/0 |
48 h | 0/1/1a | 0/1/1a | 0/0/0 | |
BPC 157 10 ng | 24 h | 0/1/1a | 0/1/1a | 0/0/0 |
48 h | 0/1/1a | 1/1/1a | 0/0/0 | |
BPC 157 1 ng | 24 h | 0/1/1a | 0/1/1a | 0/0/0 |
48 h | 0/1/1a | 0/1/1a | 0/0/0 | |
L-NAME 5 mg | 24 h | 2/2/3 | 2/2/3 | 0/0/0 |
48 h | 2/3/3 | 2/3/3 | 0/0/0 | |
L-arginine 100 mg | 24 h | 1/2/2 | 1/2/2 | 0/0/0 |
48 h | 1/2/2a | 1/2/2a | 0/0/0 | |
L-NAME 5 mg + L-arginine 100 mg | 24 h | 2/2/2 | 2/2/2 | 0/0/0 |
48 h | 2/2/2 | 2/2/2 | 0/0/0 | |
L-NAME 5 mg + BPC 157 10 μg | 24 h | 1/1/1a | 1/1/2a | 0/0/0 |
48 h | 1/1/2a | 1/1/2a | 0/0/0 | |
L-NAME 5 mg + BPC 157 10 ng | 24 h | 1/1/1a | 1/1/2a | 0/0/0 |
48 h | 1/1/2a | 1/1/2a | 0/0/0 | |
L-arginine 100 mg+ BPC 157 10 μg | 24 h | 0/1/1a | 0/1/1a | 0/0/0 |
48 h | 1/1/2a | 0/1/1a | 0/0/0 | |
L-arginine 100 mg + BPC 157 10 ng | 24 h | 0/1/1a | 0/1/1a | 0/0/0 |
48 h | 1/1/2a | 1/1/1a | 0/0/0 | |
L-NAME 5 mg + L-arginine 100 mg + BPC 157 10 μg | 24 h | 1/1/2a | 1/1/1a | 0/0/0 |
48 h | 1/1/2a | 1/1/1a | 0/0/0 | |
L-NAME 5 mg + L-arginine 100 mg + BPC 157 10 ng | 24 h | 1/1/2a | 1/1/1a | 0/0/0 |
48 h | 1/1/2a | 1/2/1a | 0/0/0 |
- Citation: Drmic D, Kolenc D, Ilic S, Bauk L, Sever M, Zenko Sever A, Luetic K, Suran J, Seiwerth S, Sikiric P. Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME. World J Gastroenterol 2017; 23(29): 5304-5312
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5304.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5304